Search results
Could Sarepta Therapeutics Become the Next Vertex Pharmaceuticals?
Motley Fool via Yahoo Finance· 4 months agoSarepta Therapeutics (NASDAQ: SRPT) and Vertex Pharmaceuticals (NASDAQ: VRTX) have a lot in common:...
Is It Too Late to Buy CRISPR Therapeutics Stock?
Motley Fool via Yahoo Finance· 3 months agoCRISPR Therapeutics (NASDAQ: CRSP) is gaining in prominence. The gene-editing specialist has made tremendous clinical and regulatory progress since its...
10 Oversold Biotech Stocks to Buy
Insider Monkey via Yahoo Finance· 10 months agoIn this article, we will take a look at the 10 oversold biotech stocks to buy. To skip our analysis of the recent trends, and market activity, you can go...
12 Stocks with Biggest Upside Potential According to Analysts
Insider Monkey via Yahoo Finance· 10 months agoIn this article, we will take a look at the 12 stocks with biggest upside potential according to...
FDA no longer requires animal testing for new drugs. Is that safe?
Live Science via Yahoo News· 1 year agoclose up on the gloved hands of a researcher holding a white lab rat with red eyes The U.S. Food and...
1 Green Flag and 1 Red Flag for Bluebird Bio Stock
Motley Fool via Yahoo Finance· 6 months agoNo stock is entirely risk-free, especially stocks like Bluebird Bio (NASDAQ: BLUE). The small-cap company's shares have plunged by 84% in the past three...
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
Motley Fool via Yahoo Finance· 1 month agoThere are several textbook arguments against monopolies. According to one of them, companies that...
Amgen taking different path to weight loss windfall
Reuters via Yahoo News· 4 months agoThe popularity of a new generation of weight-loss medicines is inspiring a growing number of drugmakers to pursue paths emulating Eli Lilly's...
Private equity acquires a taste for drug development
Reuters via Yahoo News· 1 year agoPrivate equity firms that deemed drug development too risky for their liking in the past are increasingly investing in the sector, raising dedicated...
CVS stock tumbles after Blue Shield of California shake-up. Analysts call selloff 'nonsensical'
Yahoo Finance· 10 months agoThe shake-up in pharmacy benefits manager (PBM) services announced by Blue Shield of California on...
